These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11012225)

  • 1. Regulation of expression of megakaryocyte and platelet proteoglycans.
    Schick BP
    Stem Cells; 1996; 14 Suppl 1():220-31. PubMed ID: 11012225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serglycin and betaglycan proteoglycans are expressed in the megakaryocytic cell line CHRF 288-11 and normal human megakaryocytes.
    Schick BP; Jacoby JA
    J Cell Physiol; 1995 Oct; 165(1):96-106. PubMed ID: 7559813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of mRNA for serglycin core protein and other platelet alpha granule proteins is increased in human erythroleukemia cells by phorbol myristate acetate.
    Schick BP; Thornton RD
    Leukemia; 1993 Dec; 7(12):1955-9. PubMed ID: 7504770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased serglycin proteoglycan size is associated with the platelet alpha granule storage defect in Wistar Furth hereditary macrothrombocytopenic rats. Serglycin binding affinity to type I collagen is unaltered.
    Schick BP; Pestina TI; San Antonio JD; Stenberg PE; Jackson CW
    J Cell Physiol; 1997 Jul; 172(1):87-93. PubMed ID: 9207929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Betaglycan induces TGF-beta signaling in a ligand-independent manner, through activation of the p38 pathway.
    Santander C; Brandan E
    Cell Signal; 2006 Sep; 18(9):1482-91. PubMed ID: 16413747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter regulatory elements and DNase I-hypersensitive sites involved in serglycin proteoglycan gene expression in human erythroleukemia, CHRF 288-11, and HL-60 cells.
    Schick BP; Petrushina I; Brodbeck KC; Castronuevo P
    J Biol Chem; 2001 Jul; 276(27):24726-35. PubMed ID: 11333275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of TNF-related apoptosis-inducing ligand (TRAIL) in megakaryocytes and platelets.
    Crist SA; Elzey BD; Ludwig AT; Griffith TS; Staack JB; Lentz SR; Ratliff TL
    Exp Hematol; 2004 Nov; 32(11):1073-81. PubMed ID: 15539085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NACP, a synaptic protein involved in Alzheimer's disease, is differentially regulated during megakaryocyte differentiation.
    Hashimoto M; Yoshimoto M; Sisk A; Hsu LJ; Sundsmo M; Kittel A; Saitoh T; Miller A; Masliah E
    Biochem Biophys Res Commun; 1997 Aug; 237(3):611-6. PubMed ID: 9299413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells.
    Cupit LD; Schmidt VA; Gnatenko DV; Bahou WF
    Exp Hematol; 2004 Oct; 32(10):991-9. PubMed ID: 15504554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteoglycan synthesis in human erythroleukaemia (HEL) cells.
    Schick BP; Senkowski-Richardson S
    Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):651-8. PubMed ID: 1372801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serglycin proteoglycan deletion in mouse platelets: physiological effects and their implications for platelet contributions to thrombosis, inflammation, atherosclerosis, and metastasis.
    Schick BP
    Prog Mol Biol Transl Sci; 2010; 93():235-87. PubMed ID: 20807648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in protein sulfation in human erythroleukemia (HEL), CHRF-288-11, and K562 cells following treatment with dimethyl sulfoxide or phorbol 12-myristate 13-acetate.
    Schick BP; Tang RP; Jacoby JA
    Arch Biochem Biophys; 1995 Feb; 317(1):191-200. PubMed ID: 7872784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the serglycin gene in human leukemic cell lines.
    Maillet P; Alliel PM; Mitjavila MT; Périn JP; Jollès P; Bonnet F
    Leukemia; 1992 Nov; 6(11):1143-7. PubMed ID: 1434796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular domain of TGFbeta type III receptor inhibits angiogenesis and tumor growth in human cancer cells.
    Bandyopadhyay A; Zhu Y; Malik SN; Kreisberg J; Brattain MG; Sprague EA; Luo J; López-Casillas F; Sun LZ
    Oncogene; 2002 May; 21(22):3541-51. PubMed ID: 12032856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulated expression of the alpha isoform of the human thromboxane A2 receptor during megakaryocyte differentiation: a coordinated role for WT1, Egr1, and Sp1.
    Gannon AM; Turner EC; Reid HM; Kinsella BT
    J Mol Biol; 2009 Nov; 394(1):29-45. PubMed ID: 19747485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-4 downregulates nuclear factor-erythroid 2 (NF-E2) expression in primary megakaryocytes and in megakaryoblastic cell lines.
    Catani L; Amabile M; Luatti S; Valdrè L; Vianelli N; Martinelli G; Tura S
    Stem Cells; 2001; 19(4):339-47. PubMed ID: 11463954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression.
    Gordon KJ; Dong M; Chislock EM; Fields TA; Blobe GC
    Carcinogenesis; 2008 Feb; 29(2):252-62. PubMed ID: 17999987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretion of proteases in serglycin transfected Madin-Darby canine kidney cells.
    Zernichow L; Dalen KT; Prydz K; Winberg JO; Kolset SO
    FEBS J; 2006 Feb; 273(3):536-47. PubMed ID: 16420477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation.
    Droguett R; Cabello-Verrugio C; Riquelme C; Brandan E
    Matrix Biol; 2006 Aug; 25(6):332-41. PubMed ID: 16766169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorothioate oligonucleotides cause degradation of secretory but not intracellular serglycin proteoglycan core protein in a sequence-independent manner in human megakaryocytic tumor cells.
    Schick BP; Eras JL; Mintz PS
    Antisense Res Dev; 1995; 5(1):59-65. PubMed ID: 7613073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.